Wall Street analysts gave NuVasive shares a $60.93 price target.
Here are four notes:
1. Analysts expect NuVasive to report earnings per share of $0.36 next quarter.
2. In the previous quarter, the company had EPS of $0.32.
3. Some analysts predict NuVasive to post EPS of $1.72 for the current fiscal year, while other more bearish analysts expect $1.45 EPS.
4. Analysts have a 1.4 consensus rating on NuVasive shares.
More articles on devices:
Stryker leads $84M hip & knee orthopedic surgical robot device markets: 5 key points
Disc replacement driving spine industry — KICVentures comments on industry shift: 7 insights
In light of acquisition, Zimmer Biomet joins LDR in push for Mobi-C reimbursement: 5 things to know